Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Why Does the Affordable Care Act Remain So Unpopular?

Why Does the Affordable Care Act Remain So Unpopular? News & Analysis Challenges Ahead forested areas of Guinea, or are resistant to Nonetheless, even trials with inad- Major challenges remain for the affected public health measures aimed at reducing equate statistical power to demonstrate ef- countries and international groups working the spread of Ebola virus disease. In certain ficacy can still provide useful safety and sub- to eliminate the transmission of Ebola. The regions, it is customary to wash the body in group efficacy data that can be used to gain already fragile health systems of Liberia, preparation for burial, explained Damon. If approvals for an intervention, Fauci ex- Guinea, and Sierra Leone have suffered proper precautions are not taken during this plained. Schuchat noted that the CDC serious damage. More than 800 health process, the high levels of virus still present Sierra Leone trial testing the efficacy of the workers have had confirmed Ebola infec- on the body may infect others. yet-to-be-chosen vaccine has been de- tions and at least 488 have died of the dis- Damon said that the CDC and others are signed to account for reduced cases. ease, according to the WHO. Liberia is just working to develop alternative, safe burial Some emerging evidence http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Why Does the Affordable Care Act Remain So Unpopular?

JAMA , Volume 313 (10) – Mar 10, 2015

Loading next page...
 
/lp/american-medical-association/why-does-the-affordable-care-act-remain-so-unpopular-Aiai0nVA0s
Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2015.0542
pmid
25756424
Publisher site
See Article on Publisher Site

Abstract

News & Analysis Challenges Ahead forested areas of Guinea, or are resistant to Nonetheless, even trials with inad- Major challenges remain for the affected public health measures aimed at reducing equate statistical power to demonstrate ef- countries and international groups working the spread of Ebola virus disease. In certain ficacy can still provide useful safety and sub- to eliminate the transmission of Ebola. The regions, it is customary to wash the body in group efficacy data that can be used to gain already fragile health systems of Liberia, preparation for burial, explained Damon. If approvals for an intervention, Fauci ex- Guinea, and Sierra Leone have suffered proper precautions are not taken during this plained. Schuchat noted that the CDC serious damage. More than 800 health process, the high levels of virus still present Sierra Leone trial testing the efficacy of the workers have had confirmed Ebola infec- on the body may infect others. yet-to-be-chosen vaccine has been de- tions and at least 488 have died of the dis- Damon said that the CDC and others are signed to account for reduced cases. ease, according to the WHO. Liberia is just working to develop alternative, safe burial Some emerging evidence

Journal

JAMAAmerican Medical Association

Published: Mar 10, 2015

There are no references for this article.